We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current GSS market cap is 125.88M. The company's latest EPS is AUD -0.0958 and P/E is -6.99.
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Revenue | 13.9M | 28.51M | 35.51M | 21.51M | 13.77M |
Operating Income | -2.32M | 1.59M | 2.95M | -14.59M | -18.33M |
Net Income | -2.09M | 1.76M | 3.06M | -14.05M | -17.86M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Total Assets | 49.72M | 54.05M | 59.65M | 49.08M | 67.29M |
Total Liabilities | 3.79M | 4.71M | 4.85M | 6.16M | 6.18M |
Total Equity | 45.93M | 49.34M | 54.8M | 42.91M | 61.1M |
Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
Operating | -9.49M | 4.2M | 9.81M | -12.45M | -10.12M |
Investing | -2.35M | -4.98M | -2.99M | -8.09M | -4.79M |
Financing | 36.69M | -190k | -101k | -23k | 34.82M |
Market Cap | 125.88M |
Price to Earnings Ratio | -6.99 |
Price to Sales Ratio | 9.08 |
Price to Cash Ratio | 3.45 |
Price to Book Ratio | 2.04 |
Dividend Yield | - |
Shares Outstanding | 186.48M |
Average Volume (1 week) | 58.78k |
Average Volume (1 Month) | 51.77k |
52 Week Change | 35.00% |
52 Week High | 0.85 |
52 Week Low | 0.38 |
Spread (Intraday) | 0.03 (3.57%) |
Company Name | Genetic Signatures Limited |
Address |
level 12 sydney, new south wales 2000 |
Website | https://geneticsignatures.com |
Industry | electromedical apparatus (3845) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions